metabolic · Mechanism Report
Is N-acetyl-S-phenyl-L-cysteine a urinary biomarker of benzene exposure?
N-acetyl-S-phenyl-L-cysteine is a supported urinary biomarker of recent benzene exposure.
This is what AI claimed
N-acetyl-S-phenyl-L-cysteine is formed through glutathione conjugation and is used as a urinary biomarker of benzene exposure.
Executive summary
The claim says this metabolite is formed through glutathione-related processing and measured in urine as an indicator of benzene exposure. The mechanism frames it as a downstream mercapturate end product, produced after benzene is metabolized and then excreted. Smoking can raise measured levels and affect interpretation, especially at lower exposure levels.
Verified conclusion
N-acetyl-S-phenyl-L-cysteine—more commonly called S-phenylmercapturic acid (SPMA)—is a well-established urinary marker of recent benzene exposure. The claim is scientifically supported, with the important qualification that SPMA is produced downstream of the initial glutathione-conjugation step.
Metabolic mechanism
- Benzene is oxidized chiefly via CYP2E1 to benzene oxide, a reactive intermediate.
- Glutathione captures a fraction of benzene oxide, initiating the mercapturate pathway. The glutathione conjugate is subsequently processed through cysteinylglycine and cysteine conjugates; terminal N-acetylation produces SPMA.
- Thus, SPMA is a glutathione-derived end product rather than the immediate product of glutathione conjugation. It is excreted in urine and is not, by itself, evidence of glutathione depletion or benzene toxicity.
- This pathway represents only a minor fraction of overall benzene metabolism, but its relative specificity makes it useful for exposure monitoring.
Biomonitoring evidence and interpretation
- Occupational studies support post-shift urinary SPMA as correlating with personal airborne benzene measurements, particularly at exposures around or above approximately 0.3 ppm.
- SPMA mainly reflects recent exposure: urinary concentrations peak near the end of a work shift, and its elimination half-life is approximately 9 hours.
- End-of-shift sampling, creatinine adjustment, and—when practical—paired pre-/post-shift samples improve interpretation.
Practical limitations
- Smoking raises urinary SPMA and can materially confound assessment of low-level occupational exposure.
- Below roughly 0.25 ppm airborne benzene, the quantitative exposure–SPMA relationship is inconsistent.
- Acid-dependent conversion of a urinary precursor to SPMA during specimen processing can affect measured concentrations; validated collection and analytical methods matter.
Bottom line
- SPMA is a supported, relatively specific urinary biomarker of recent benzene exposure, formed through multistep processing of a benzene–glutathione conjugate; results require context regarding timing, smoking, urine dilution, exposure level, and laboratory method.
References
- Large Differences in Urinary Benzene Metabolite S-Phenylmercapturic Acid Quantitation: A Comparison of Five LC–MS-MS Methods — pmc.ncbi.nlm.nih.gov
- Full article: The mercapturic acid pathway — tandfonline.com
- 4. Mechanistic and Other Relevant Data - Benzene - NCBI Bookshelf — ncbi.nlm.nih.gov
- Evidence That Humans Metabolize Benzene via Two Pathways — pmc.ncbi.nlm.nih.gov
- Biological exposure indices of occupational ... - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Biological monitoring of exposure to benzene - NIH — pmc.ncbi.nlm.nih.gov
- Application of the urinary S-phenylmercapturic acid test as ... — pmc.ncbi.nlm.nih.gov
- Biological Monitoring of Exposure to Benzene in Port ... — frontiersin.org
- Full article: Human biomonitoring of low-level benzene exposures — tandfonline.com
- Microsoft Word - IH_PDF扉ひな型.docx — jstage.jst.go.jp
- Biological exposure indices of occupational exposure to benzene: A systematic review — cell.com
See a full patient report verified like this
Book a walkthrough